Allergy Therapeutics Plc is a UK-based pharmaceutical company. It mainly aims on the treatment and prevention of allergy with aluminum-free products. It was founded in the year 2004 and its headquarters are situated in Worthing, United Kingdom. With a strong and well-established presence in Europe, the company runs its operations in 19 markets, either directly or through partnerships. It has many subsidiaries, which include Allergy Therapeutics (Uk) Limited, Allergy Therapeutics Iberica S.L., Allergy Therapeutics Italia S.R.L., and Alerpharma S.A. etc. The company is listed on the Alternative Investment Market (AIM) of the London Stock Exchange and is also a constituent of the FTSE AIM All-Share index. It complies with the UK City Code on Takeovers and Mergers.
The goal of the company is to transform the lives of patients for the better, deliver convenience, offer special expertise, and focus on research and development. The product range of the company includes a wide range of pioneering aluminium-free allergy vaccines and diagnostics. It also offers short course of treatments which are highly efficient as well as convenient. The adjuvant technologies used by the company enhance the therapies by increasing their efficacy. This concept is further being developed in Bencard Adjuvant Systems, which is its specialist business, for bettering the health and examining vaccinations for infectious diseases and cancer treatments. The main market of the group is Germany, and it has generated over 60% of its revenue in the 12 months ending 30 June 2019. It is also growing its focus on the US market.
Allergy Therapeutics Plc follows a well-defined framework of corporate governance and aligns itself with the Quoted Companies Alliance (QCA) Corporate Governance Code. Its board has set up separate committees for audit and remuneration. It has an ethical code of conduct for running its business operations and promotes a culture of trust, transparency, accountability, equality, and diversity. It has a Corporate Social Responsibility (CSR) framework in place, and it actively works with customers, suppliers, employees, and partners under its responsible business framework. Apart from fulfilling all its corporate responsibilities, the company also fulfils its environmental and social responsibilities and complies with international best practices and guidelines to create a sustainable business. It aims to minimize the impact of its business activities on the environment and create long-term value for the business as well as the wider community.
Allergy Therapeutics PLC Dominion Way WORTHING BN14 8SA United Kingdom GBR
+44 190 384 4700